Patrick SOON-SHIONG,Kayvan NIAZI,Shahrooz RABIZADEH
申请号：
US16702275
公开号：
US20200109366A1
申请日:
2019.12.03
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Cancer immunotherapy using genetically engineered NK cells is enhanced by expression of recombinant co-stimulatory molecules to deliver co-stimulatory signals to a recipient host's immune cells to enhance an immune response.
